Sepracor hires execs from Novartis, GSK

Share this article:

Sepracor hired four former Novartis and GlaxoSmithKline marketing and sales executives as it firmed up its senior commercial management staff.

The Massachusetts company, whose biggest product is the sleep drug Lunesta, appointed Mark Iwicki EVP and chief commercial officer, a new position. Iwicki joined from Novartis, where he led the cardiovascular business franchise.

Also from Novartis, Sepracor brought in Jay Smith as SVP of sales. At Novartis Smith served as national VP of sales and head of cardiovascular innovations marketing.

The two former GSK executives included Dean Giovanniello, whom Sepracor hired as VP of marketing, and Thomas Hoover, named VP of new products planning. Giovanniello was most recently executive director of marketing for GSK's migraine products, while Hoover served as its therapy area head, business and commercial analysis.

Sepracor said the new hires were part of an effort “to deliver enhanced performance and productivity across our commercial organization.”

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.